Literature DB >> 33632235

Health-related quality of life and self-reported cognitive function in patients with delayed neurocognitive recovery after radical prostatectomy: a prospective follow-up study.

Ursula Kahl1, Sarah Callsen1, Stefanie Beck1, Hans Pinnschmidt2, Franziska von Breunig1, Alexander Haese3, Markus Graefen3, Christian Zöllner1, Marlene Fischer4,5.   

Abstract

BACKGROUND: Delayed neurocognitive recovery (DNCR) is a common and serious complication after radical prostatectomy. We hypothesized that patients with DNCR in the early postoperative period would report reduced health-related quality of life (HRQoL) and more cognitive failures 12 months after surgery, compared with patients without DNCR.
METHODS: We performed a 12-month follow-up on 367 patients who had been enrolled in a prospective observational trial to study the incidence of DNCR after radical prostatectomy. Patients were screened for preoperative cognitive impairment and depression. We defined DNCR as a decline in cognitive function between days 3 and 5 after surgery, compared with baseline assessments. We evaluated HRQoL and cognitive failures 12 months after surgery with the 36-item Short Form Health Survey and the Cognitive Failures Questionnaire. General linear models were used to analyze associations of DNCR with HRQoL and cognitive failures.
RESULTS: Delayed neurocognitive recovery in the early postoperative period was significantly associated with self-reported cognitive failures (B for no DNCR =  - 0.411 [95% CI: - 0.798;0.024], p = 0.038), but not with physical (B = 0.082 [95% CI: - 0.021;0.186], p = 0.118) or mental HRQoL (B =  - 0.044 [95% CI: - 0.149;0.062], p = 0.417) 12 months after surgery. Preoperative depression screening scores were significantly associated with self-reported cognitive failures and both physical and mental HRQoL 12 months after surgery.
CONCLUSIONS: Delayed neurocognitive recovery in the early period after radical prostatectomy has a long-term impact on patients' daily lives by impairing memory, attention, action, and perception. Therefore, prevention of DNCR must be a priority for physicians and researchers. Consequent preoperative screening for depressive symptoms may facilitate early psycho-oncological intervention to improve postoperative HRQoL. Trials registration DRKS00010014 , date of registration: 21.03.2016, retrospectively registered.

Entities:  

Keywords:  Cognitive failures; Delayed neurocognitive recovery; Postoperative cognitive dysfunction; Prostate cancer; Quality of life; Radical prostatectomy

Mesh:

Year:  2021        PMID: 33632235      PMCID: PMC7908756          DOI: 10.1186/s12955-021-01705-z

Source DB:  PubMed          Journal:  Health Qual Life Outcomes        ISSN: 1477-7525            Impact factor:   3.186


  36 in total

1.  Trail Making Test A and B: normative data stratified by age and education.

Authors:  Tom N Tombaugh
Journal:  Arch Clin Neuropsychol       Date:  2004-03       Impact factor: 2.813

Review 2.  Postoperative Cognitive Dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the Elderly.

Authors:  Miles Berger; Jacob W Nadler; Jeffrey Browndyke; Niccolo Terrando; Vikram Ponnusamy; Harvey Jay Cohen; Heather E Whitson; Joseph P Mathew
Journal:  Anesthesiol Clin       Date:  2015-07-16

3.  Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer.

Authors:  Michael A Kozminski; Ganesh S Palapattu; Rohit Mehra; Jeffrey S Montgomery; Alon Z Weizer; Ted A Skolarus; Brent K Hollenbeck; David C Miller; Chang He; Scott Tomlins; James E Montie; Felix Y Feng; David P Wood; Lakshmi P Kunju; Todd M Morgan
Journal:  Urology       Date:  2014-06-21       Impact factor: 2.649

4.  Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joint replacement surgery.

Authors:  Brendan Silbert; Lisbeth Evered; David A Scott; Stephen McMahon; Peter Choong; David Ames; Paul Maruff; Konrad Jamrozik
Journal:  Anesthesiology       Date:  2015-06       Impact factor: 7.892

5.  The Relevance of Postoperative Cognitive Decline in Daily Living: Results of a 1-Year Follow-up.

Authors:  Sabrina Kastaun; Tibo Gerriets; Niko P Schwarz; Mesut Yeniguen; Markus Schoenburg; Christian Tanislav; Martin Juenemann
Journal:  J Cardiothorac Vasc Anesth       Date:  2015-12-03       Impact factor: 2.628

6.  A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer.

Authors:  Sanoj Punnen; Janet E Cowan; Laura B Dunn; Dianne M Shumay; Peter R Carroll; Matthew R Cooperberg
Journal:  BJU Int       Date:  2013-07       Impact factor: 5.588

7.  Postoperative cognitive dysfunction and neuroinflammation; Cardiac surgery and abdominal surgery are not the same.

Authors:  Iris B Hovens; Barbara L van Leeuwen; Massimo A Mariani; Aletta D Kraneveld; Regien G Schoemaker
Journal:  Brain Behav Immun       Date:  2016-02-08       Impact factor: 7.217

8.  Postoperative cognitive dysfunction is independent of type of surgery and anesthetic.

Authors:  Lisbeth Evered; David A Scott; Brendan Silbert; Paul Maruff
Journal:  Anesth Analg       Date:  2011-04-07       Impact factor: 5.108

Review 9.  Systemic treatments for high-risk localized prostate cancer.

Authors:  Géraldine Pignot; Denis Maillet; Emmanuel Gross; Philippe Barthelemy; Jean-Baptiste Beauval; Friederike Constans-Schlurmann; Yohann Loriot; Guillaume Ploussard; Paul Sargos; Marc-Olivier Timsit; Sébastien Vincendeau; Gilles Pasticier; Delphine Borchiellini
Journal:  Nat Rev Urol       Date:  2018-08       Impact factor: 14.432

10.  Impact of preoperative anxiety and depression on quality of life before and after resection of hepatocellular carcinoma.

Authors:  Hao-Hsien Lee; Chong-Chi Chiu; Jin-Jia Lin; Jhi-Joung Wang; King-Teh Lee; Ding-Ping Sun; Hon-Yi Shi
Journal:  J Affect Disord       Date:  2018-12-25       Impact factor: 4.839

View more
  1 in total

Review 1.  Perioperative neurocognitive disorders: A narrative review focusing on diagnosis, prevention, and treatment.

Authors:  Hao Kong; Long-Ming Xu; Dong-Xin Wang
Journal:  CNS Neurosci Ther       Date:  2022-06-01       Impact factor: 7.035

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.